Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

S. T. Lee; M. Ghanem; R. A. Herbertson; S. U. Berlangieri; A. J. Byrne; K. Tabone; P. Mitchell; S. R. Knight; M. Feigen; A. M. Scott

首页> 外文期刊>Molecular Imaging and Biology >Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

【24h】

Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

机译：18 F-FDG PET / CT在恶性胸膜间皮瘤患者中的预后价值

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

To evaluate prognostic value of integrated 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography/computed tomography (FDG-PET/CT) and correlate histopathological subtype with maximum standardized uptake value (SUVmax) and survival in patients with malignant mesothelioma (MM).

机译：评价整合的2-脱氧-2- [F-18]氟-d-葡萄糖-正电子发射断层扫描/计算机断层扫描（FDG-PET / CT）的预后价值，并将组织病理学亚型与最大标准化摄取值（SUVmax ）和恶性间皮瘤（MM）患者的生存率。

著录项

来源
《Molecular Imaging and Biology》 |2009年第6期|473-479|共7页
作者
S. T. Lee; M. Ghanem; R. A. Herbertson; S. U. Berlangieri; A. J. Byrne; K. Tabone; P. Mitchell; S. R. Knight; M. Feigen; A. M. Scott;
展开▼
作者单位

Centre for PET Austin Health Heidelberg Victoria 3084 Australia;

Centre for PET Austin Health Heidelberg Victoria 3084 Australia;

Ludwig Institute for Cancer Research Melbourne Centre for Clinical Sciences Austin Health Heidelberg Victoria Australia;

Centre for PET Austin Health Heidelberg Victoria 3084 Australia;

Centre for PET Austin Health Heidelberg Victoria 3084 Australia;

Centre for PET Austin Health Heidelberg Victoria 3084 Australia;

Department of Medicine University of Melbourne Austin Health Heidelberg Australia;

Department of Thoracic Surgery Austin Health Heidelberg Victoria Australia;

Department of Radiation Oncology Austin Health Heidelberg Victoria Australia;

Centre for PET Austin Health Heidelberg Victoria 3084 Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
FDG-PET/CT; Mesothelioma; Prognosis; PET;

机译：FDG-PET / CT;间皮瘤;预后;PET;

相似文献

外文文献
中文文献
专利

1. Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma. [J] . Molecular imaging and biology: MIB : the official publication of the Academy of Molecular Imaging . 2009,第6期

机译：18F-FDG PET / CT对恶性胸膜间皮瘤患者的预后价值。
2. Prognostic Value of 18F-FDG Standard Uptake Value by Integrated PET/CT in the Staging of Malignant Pleural Mesothelioma. [J] . G Genestreti, A Moretti, S Piciucchi, Technology in cancer research & treatment. . 2012,第2期

机译：PET / CT结合18F-FDG标准摄取值在恶性胸膜间皮瘤分期中的预后价值。
3. Prognostic Value of 18F-FDG Standard Uptake Value by Integrated PET/CT in the Staging of Malignant Pleural Mesothelioma [J] . G. Genestreti, A. Moretti, S. Piciucchi, Technology in cancer research & treatment. . 2012,第2期

机译：PET / CT结合18F-FDG标准摄取值在恶性胸膜间皮瘤分期中的预后价值
4. An MRM assay for HAPLN1 - a protein with potential as a prognostic marker for malignant pleural mesothelioma (MPM) [C] . Sofia Waldemarson, Chandra M.V. Goparaju, Asa Wahlander, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：HAPLN1的MRM测定 - 一种蛋白质，其具有恶性胸膜间皮瘤（MPM）的预后标志物
5. An economic analysis of the addition of bevacizumab to standard chemotherapy in patients with malignant pleural mesothelioma. [D] . Malacan, Jean. 2016

机译：恶性胸膜间皮瘤患者在标准化疗中加用贝伐单抗的经济分析。
6. 18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center [O] . Hugh S Elliott, Ur Metser, Marc de Perrot, 2018

机译：18F-FDG PET / CT在考虑用于多模式治疗的恶性胸膜间皮瘤患者的治疗中：三级转诊中心的经验
7. P1.06-10 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Diagnostic/Prognostic Performance and Correlation with Pathological Results [O] . F. Lococo, O. Rena, F. Torricelli, 2019

机译：P1.06-10 18F-FDG PET / CT在恶性胸腔间皮瘤中：诊断/预后性能和与病理结果的相关性

Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

摘要

著录项

相似文献

相关主题

期刊订阅